[Treatment of hepatitis C virus infection: current status and perspectives].

Abstract excerpt

Current treatment of patients with chronic hepatitis C consists of pegylated interferon and ribavirin. The application of viral kinetics is currently allowing treatment to be optimized by varying the length of treatment to 24 weeks for genotypes 2 and 3 and 48 weeks for the remaining genotypes. Thus, patients with genotype 1, with a low viral load, and rapid virological response (RVR) obtain a high RVS with 24...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Clinical Trials as Topic
• Share to Drug Administration Schedule
• Share to Interferon-alpha